What is OS Therapies's free cash flow yield?

OS Therapies (OSTX) reported free cash flow yield of -29.8% in Q4 2025.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

OS Therapies OSTX Free cash flow yield

Free cash flow yield at other companies

ImmunomeIMNM

-8.3%-3.4pp

Avalo TherapeuticsAVTX

-63.1%-29.0pp

Arcus BiosciencesRCUS

-18.1%—

ImmunityBio, Inc.IBRX

-3.8%-1.6pp

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

-66.2%—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Calculated from OS Therapies’s reported figures.

free cash flow/market cap=-29.8%

Based on trailing twelve months.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's free cash flow yield?: OS Therapies (OSTX) reported free cash flow yield of -29.8% in Q4 2025.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.